Power Law company profile

Axonics

Biotech & Life Sciences · Irvine, United States · Founded 2012 · IPO 2018 Unicorn

Company developing novel implantable neuromodulation

Valuation

$2.5–5B

Latest valuation · 2026

Unlock exact value

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

6 investors on Axonics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Legend Capital

Andera Partners

Series B+ 4 investors entered at this stage

Longitude Capital

Cormorant Asset Management

Advent Life Sciences

Glide Health

Global footprint

Where Axonics has talent and traffic

AI talent share

0.3% of workforce is AI talent
(1 of 320 staff)

Core AI00%

Other AI10.31%

Non-AI workforce31999.69%

Workforce by country

6 countries with
team presence

🇺🇸 United States97.1%

🇦🇺 Australia1.3%

🇬🇧 United Kingdom0.9%

🇩🇪 Germany0.4%

🇮🇳 India0.2%

Top 5 of 6 shown

Web traffic by country

35K monthly visits
across markets

🇺🇸 United States81.1%

🇬🇧 United Kingdom7.1%

🇮🇳 India3.1%

🇯🇵 Japan3.1%

🇨🇦 Canada2.6%

Top 5 markets shown

Patent intelligence

$65M patent portfolio · 57 active families

Estimated portfolio value

$65M

1.8% of valuation · 14.4× smaller than top peer Globus Medical ($930M)

57 active patent families

Where Axonics innovates Biomedical engineeringPhysical therapyNeurostimulationPulse generatorImplantable Neurostimulators

Where Axonics concentrates vs peers

Each axis is a top-10 topic across Axonics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Axonics

An AI-synthesized read of the highest-engagement posts about Axonics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Axonics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles